Is gabapentin effective and safe in the treatment of chronic pelvic pain in women: a systematic review and meta-analysis

ConclusionThis systematic review and meta-analysis demonstrated that for women with CPP, gabapentin was significantly different from placebo in average pain scores at 3 and 6 months. However, the two drugs did not differ in the reduction in pain scores from baseline. Gabapentin can bring more significant side effects, whether they are common side effects or serious side effects.
Source: International Urogynecology Journal and Pelvic Floor Dysfunction - Category: OBGYN Source Type: research